Private Finance: Rey Assurance, TreeFrog Therapeutics, HaemaLogiX,, Klaim, Newron Pharmaceutical

Italy: Newron Pharmaceutical, a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system, has drawn down Tranche 4 of its financing agreement with the European Investment Bank (EIB) signed in October 2018. The financing agreement comprises up to €40m in funds, subject to the company…

You must be a HMI Subscriber to view this content.

Subscribe Now »